Tactile Systems Technology, Inc. (TCMD)
NASDAQ: TCMD · Real-Time Price · USD
29.41
+0.81 (2.83%)
At close: Jul 16, 2026, 4:00 PM EDT
29.99
+0.58 (1.97%)
After-hours: Jul 16, 2026, 4:22 PM EDT
TCMD Revenue
Tactile Systems Technology had revenue of $75.27M in the quarter ending March 31, 2026, with 22.85% growth. This brings the company's revenue in the last twelve months to $343.52M, up 17.18% year-over-year. In the year 2025, Tactile Systems Technology had annual revenue of $329.52M with 12.47% growth.
Revenue (ttm)
$343.52M
Revenue Growth
+17.18%
P/S Ratio
1.93
Revenue / Employee
$316,318
Employees
1,086
Market Cap
663.38M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 329.52M | 36.54M | 12.47% |
| Dec 31, 2024 | 292.98M | 18.56M | 6.76% |
| Dec 31, 2023 | 274.42M | 27.64M | 11.20% |
| Dec 31, 2022 | 246.79M | 38.73M | 18.61% |
| Dec 31, 2021 | 208.06M | 20.93M | 11.18% |
| Dec 31, 2020 | 187.13M | -2.36M | -1.25% |
| Dec 31, 2019 | 189.49M | 45.74M | 31.82% |
| Dec 31, 2018 | 143.75M | 34.47M | 31.54% |
| Dec 31, 2017 | 109.28M | 24.74M | 29.26% |
| Dec 31, 2016 | 84.54M | 21.67M | 34.47% |
| Dec 31, 2015 | 62.87M | 15.14M | 31.71% |
| Dec 31, 2014 | 47.74M | 10.56M | 28.41% |
| Dec 31, 2013 | 37.18M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OrthoPediatrics | 243.30M |
| Cerus | 216.56M |
| SI-BONE | 206.22M |
| Cytek Biosciences | 204.17M |
| Pacific Biosciences of California | 160.03M |
| Beta Bionics | 110.24M |
| NeuroPace | 99.53M |
| CeriBell | 95.07M |
TCMD News
- 3 days ago - Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients - GlobeNewsWire
- 6 weeks ago - Tactile Systems Technology Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 6 weeks ago - Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy - GlobeNewsWire
- 2 months ago - Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference - GlobeNewsWire
- 2 months ago - Tactile Systems upgraded to Buy from Neutral at B. Riley - TheFly
- 2 months ago - Tactile Systems upgraded to Buy from Neutral at B. Riley - TheFly
- 2 months ago - Tactile Systems price target raised to $40 from $38 at BTIG - TheFly
- 2 months ago - Tactile Systems Technology Earnings Call Transcript: Q1 2026 - Transcripts